1) Olmesartan
奥美沙坦
1.
Determination of olmesartan concentration by LC-MS-MS assay in the human plasma;
LC-MS-MS方法检测人血浆中奥美沙坦的浓度
2.
Pharmacokinetics and bioequivalence of olmesartan medoxomil capsules;
奥美沙坦酯胶囊的人体药动学及生物等效性
3.
Efficacy and safety of olmesartan medoxomil tablet in patients with mild to moderate primary hypertension;
奥美沙坦治疗轻、中度原发性高血压的疗效和安全性
2) olmesartan medoxomil
奥美沙坦酯
1.
Determination of fourteen kinds of organic residual in olmesartan medoxomil by capillary gas chromatography;
毛细管气相色谱法测定奥美沙坦酯中14种有机溶剂的残留量
2.
Bioequivalence of olmesartan medoxomil tablet in healthy volunteers;
奥美沙坦酯片人体生物等效性研究
3.
A novel synthesis of olmesartan medoxomil and examination of its related impurities;
抗高血压药奥美沙坦酯合成新路线和相关杂质的研究
4) olmesartan medoxomil tablet
奥美沙坦酯片
1.
Effects and safety of mild and moderate primary hypertension treated with olmesartan medoxomil tablet;
奥美沙坦酯片治疗轻中度原发性高血压的疗效和安全性
5) Intermediates of Olmesartan
奥美沙坦中间体
6) Compound olmesartan medoxomil tablet
复方奥美沙坦酯片
1.
OBJECTIVE The pharmacokinetics of hydrochlorothiazide and olmesartan was investigated in healthy volunteers after single administration of compound olmesartan medoxomil tablets.
目的研究健康受试者口服复方奥美沙坦酯片的药物动力学特征。
补充资料：奥美沙坦
分子式：暂无
分子量：暂无
CAS号：暂无
性质：暂无
制备方法：暂无
用途：暂无
分子量：暂无
CAS号：暂无
性质：暂无
制备方法：暂无
用途：暂无
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条